Patents by Inventor Hans-Joachim Wallny

Hans-Joachim Wallny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200384108
    Abstract: The present invention relates to novel pharmaceutical formulations, in particular novel pharmaceutical formulations in which the active ingredient comprises human antibodies to human interleukin I beta (IL-1?), in particular ACZ885 antibody, pharmaceutical formulations which are stable and aggregate-free upon storage and delivery.
    Type: Application
    Filed: July 16, 2020
    Publication date: December 10, 2020
    Inventors: Jóachim Momm, Hans-Joachim Wallny
  • Patent number: 10010513
    Abstract: The present invention is directed to an aqueous pharmaceutical composition, particularly an aqueous ophthalmic composition, suitable as an injection, particularly an intravitreal injection. The composition includes a biologic therapeutic agent (e.g., an isolated monoclonal antibody that specifically binds to a C5 protein) that tends to raise the viscosity of the composition and a guanidine and/or guanidine derivative (e.g., L-arginine) that tends to lower the viscosity of the composition.
    Type: Grant
    Filed: May 23, 2013
    Date of Patent: July 3, 2018
    Assignee: Novartis AG
    Inventors: David Schmitt, Hans-Joachim Wallny
  • Patent number: 8623367
    Abstract: The present invention relates to novel pharmaceutical formulations, in particular novel pharmaceutical formulations in which the active ingredient comprises human antibodies to human interleukin I beta (IL-1?), in particular ACZ885 antibody, pharmaceutical formulations which are stable and aggregate-free upon storage and delivery.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: January 7, 2014
    Assignee: Novartis AG
    Inventors: Joachim Momm, Hans-Joachim Wallny
  • Publication number: 20130317457
    Abstract: The present invention is directed to an aqueous pharmaceutical composition, particularly an aqueous ophthalmic composition, suitable as an injection, particularly an intravitreal injection. The composition includes a biologic therapeutic agent (e.g., an isolated monoclonal antibody that specifically binds to a C5 protein) that tends to raise the viscosity of the composition and a guanidine and/or guanidine derivative (e.g., L-arginine) that tends to lower the viscosity of the composition.
    Type: Application
    Filed: May 23, 2013
    Publication date: November 28, 2013
    Inventors: David Schmitt, Hans-Joachim Wallny
  • Publication number: 20120315285
    Abstract: The present invention relates to novel pharmaceutical formulations, in particular novel pharmaceutical formulations in which the active ingredient comprises human antibodies to human interleukin I beta (IL-1?), in particular ACZ885 antibody, pharmaceutical formulations which are stable and aggregate-free upon storage and delivery.
    Type: Application
    Filed: August 15, 2012
    Publication date: December 13, 2012
    Inventors: Joachim Momm, Hans-Joachim Wallny
  • Publication number: 20110236398
    Abstract: The present invention relates to novel pharmaceutical formulations, in particular novel pharmaceutical formulations in which the active ingredient comprises human antibodies to human interleukin 1 beta (IL-1?), in particular ACZ885 antibody, pharmaceutical formulations which are stable and aggregate-free upon storage and delivery.
    Type: Application
    Filed: December 9, 2009
    Publication date: September 29, 2011
    Inventors: Joachim Momm, Hans-Joachim Wallny